The department of Libya's Ministry of Health that WHO described in 2018 as the country's drug regulatory authority, responsible for registering medicines. No Libyan regulator is on WHO's August 2026 list of regulators at maturity level 3 or 4, and OnCo found nothing newer than 2018 on its work.
WHO wrote on 12 April 2018 that it had run a workshop in Tripoli for the Pharmacy Administration, Libya's drug regulatory authority, based in the Ministry of Health, to set up SIAMED, WHO's model system for computer-assisted drug registration; seven staff of its Registration Department took part, under a European Union funded project. A WHO note of 30 December 2018 records the Pharmacy Administration and the Medical Supply Organization among the bodies that agreed guidelines for selecting, procuring, storing and distributing medicines, to be sent for ministerial approval.
A 2010 review in the Libyan Journal of Medicine says the Health Law, Act 106 of 1973, requires a medicine to be registered with the Ministry of Health before it is available on the Libyan market. Libya is not on WHO's August 2026 list of regulators at maturity level 3 or 4. OnCo found no website with a register of approved medicines or registration rules: the pharmacy system linked from the Ministry's site did not resolve on 16 November 2026. How its work is divided with the Food and Drug Control Centre was not established. The coordinates are an approximate Tripoli city point.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/